Key result
HF-specific medication was not prescribed to 42% of newly diagnosed heart failure patients within 30 days, and hospitalization did not have a major impact on prescribing patterns.
Population
235,758 adult patients with newly diagnosed heart failure in the United States, with continuous medical and…
Design
Cohort
Follow-up
median 28 months
Authors
Loading...
Gaps in early HF prescribing persist post-diagnosis; this Level 4 analysis leaves open whether targeted interventions improve initiation rates.
Cohort (n=235,758)
More than one third of newly diagnosed heart failure patients do not receive guideline-directed medical therapy within 30 days of diagnosis, and hospitalization does not significantly improve prescribing patterns.
Deschaseaux et al. (2016) conducted a cohort in Heart failure (n=235,758). Heart failure-specific medications (ACEI, ARB, BB, AA) was evaluated on Treatment initiation pattern within 30 days post-index, subsequent modifications, hospitalizations, and adherence. HF-specific medication was not prescribed to 42% of newly diagnosed heart failure patients within 30 days, and hospitalization did not have a major impact on prescribing patterns.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: